|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM364169710 |
003 |
DE-627 |
005 |
20240410232250.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2023.109817
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1371.xml
|
035 |
|
|
|a (DE-627)NLM364169710
|
035 |
|
|
|a (NLM)37925120
|
035 |
|
|
|a (PII)S1521-6616(23)00580-6
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Paardekooper, Laurent M
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Autoantibody subclass predominance is not driven by aberrant class switching or impaired B cell development
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 16.12.2023
|
500 |
|
|
|a Date Revised 10.04.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
|
520 |
|
|
|a A subset of autoimmune diseases is characterized by predominant pathogenic IgG4 autoantibodies (IgG4-AID). Why IgG4 predominates in these disorders is unknown. We hypothesized that dysregulated B cell maturation or aberrant class switching causes overrepresentation of IgG4+ B cells and plasma cells. Therefore, we compared the B cell compartment of patients from four different IgG4-AID with two IgG1-3-AID and healthy donors, using flow cytometry. Relative subset abundance at all maturation stages was normal, except for a, possibly treatment-related, reduction in immature and naïve CD5+ cells. IgG4+ B cell and plasma cell numbers were normal in IgG4-AID patients, however they had a (sub)class-independent 8-fold increase in circulating CD20-CD138+ cells. No autoreactivity was found in this subset. These results argue against aberrant B cell development and rather suggest the autoantibody subclass predominance to be antigen-driven. The similarities between IgG4-AID suggest that, despite displaying variable clinical phenotypes, they share a similar underlying immune profile
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Autoimmune encephalitis
|
650 |
|
4 |
|a IgG4
|
650 |
|
4 |
|a Myasthenia gravis
|
650 |
|
4 |
|a Pemphigus
|
650 |
|
4 |
|a Plasma cells
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin G
|2 NLM
|
700 |
1 |
|
|a Fillié-Grijpma, Yvonne E
|e verfasserin
|4 aut
|
700 |
1 |
|
|a van der Sluijs-Gelling, Alita J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zlei, Mihaela
|e verfasserin
|4 aut
|
700 |
1 |
|
|a van Doorn, Remco
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Vermeer, Maarten H
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Paunovic, Manuela
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Titulaer, Maarten J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a van der Maarel, Silvère M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a van Dongen, Jacques J M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Verschuuren, Jan J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Huijbers, Maartje G
|e verfasserin
|4 aut
|
700 |
0 |
|
|a T2B consortium
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 257(2023) vom: 22. Dez., Seite 109817
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:257
|g year:2023
|g day:22
|g month:12
|g pages:109817
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109817
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 257
|j 2023
|b 22
|c 12
|h 109817
|